



Evidence suggests that periods of heavy intense training can result in impaired immune cell 2 
function, whether this leaves elite athletes at greater risk of infections and upper respiratory 3 
symptoms is still debated.  There is some evidence that episodes of upper-respiratory symptoms 4 
do cluster around important periods of competition and intense periods of training. Since 5 
reducing upper respiratory symptoms, primarily from an infectious origin, may have 6 
implications for performance, a large amount of research has focused on nutritional strategies 7 
to improve immune function at rest and in response to exercise. Although there is some 8 
convincing evidence that meeting requirements of high intakes in carbohydrate and protein and 9 
avoiding deficiencies in nutrients such as vitamin D and antioxidants is integral for optimal 10 
immune health, well-powered randomised controlled trials reporting improvements in upper-11 
respiratory symptoms beyond such intakes are lacking. Consequently, there is a need to first 12 
understand whether the nutritional practices adopted by elite athletes increases their risk of 13 
upper respiratory symptoms. Second, promising evidence in support of efficacy and 14 
mechanisms of immune-enhancing nutritional supplements (probiotics, bovine colostrum) on 15 
upper respiratory symptoms needs to be followed up with more randomised controlled trials in 16 
elite athletes with sufficient participant numbers and rigorous procedures with clinically 17 
relevant outcome measures of immunity.  18 
 19 
Highlights 20 
- Evidence suggests that upper-respiratory symptoms in athletes typically cluster around 21 
intense periods of training, with greater risk during the winter months. 22 
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- Emerging evidence supports the use of probiotics and bovine colostrum to enhance 23 
immune health and reduce URS, to further elucidate mechanisms and efficacy well-24 
powered randomised control trials in athletes are warranted 25 
- Exercise in a state of mild hypohydration (1-3%) may not detrimentally affect mucosal 26 
immunity, with little evidence for an association between hypohydration and self-27 
reported URS 28 
- Randomised control trials to establish how periodised carbohydrate intake can impact 29 
self-reported URS and in-vivo measures of immune function in athletes are warranted 30 
- Limited evidence to support to the use of protein and amino acid supplementation to 31 
reduced URS 32 
- Antioxidant and vitamin D supplementation may be warranted in those who are 33 
deficient and exposed to extreme unaccustomed acute physical stress, however 34 
randomised control trials tracking changes in URS and immunological markers in 35 
athletes are needed.   36 
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Introduction 41 
The relationship between infection risk and exercise training load has long been described as a 42 
J-shaped curved (Figure 1), with high training loads believed to increase the risk of 43 
opportunistic infections, particularly of the upper respiratory tract (Nieman, 1994). However, 44 
there is limited empirical evidence that elite athletes experience more infections than the 45 
general population (Svendsen, Taylor, Tonnessen, Bahr & Gleeson, 2016). Based on re-46 
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evaluation of published data, Malm (2006) proposed that elite training is associated with a 47 
lower susceptibility to infection compared to high exercise workloads, whereby the relationship 48 
between infection risk and training load instead resembles an S-shaped curve (Figure 1)(Malm, 49 
2006). Whilst this remains to be verified in prospective studies, it is hypothesised that to 50 
maintain elite athlete status there is a pre-requisite to have a robust immune system capable of 51 
withstanding infections even during heightened physical and psychological stress. However, it 52 
may be that the reduced infection risk in elite athletes observed in previous studies may not 53 
reflect a lower impact of physical stress (exercise workload) per se but rather a reflection of 54 
better preventive and treatment strategies in place within the studied elite settings. 55 
Nevertheless, although elite athletes may not experience a greater annual incidence rate of 56 
infections, there is increasing recognition that episodes of upper-respiratory symptoms (URS) 57 
typically cluster around  intense periods of training (Hellard, Avalos, Guimaraes, Toussaint & 58 
Pyne, 2015; Moreira, Delgado, Moreira & Haahtela, 2009; Svendsen, Gleeson, Haugen & 59 
Tønnessen, 2015; Svendsen et al., 2016) with a greater risk during winter months (Hellard et 60 
al., 2015; Spence et al., 2007).  61 
URS is the most common medical complaint affecting athletes, and with medals often being 62 
decided by the smallest of margins, even minor illnesses can have a meaningful, negative 63 
impact on competition outcomes. Indeed, fewer days of illness appears to be one factor that 64 
differentiates World and Olympic medallists from other international-level athletes (Svendsen 65 
et al., 2015). URS in athletes is likely to involve both infectious and non-infectious causes, 66 
previous reports suggest between 31% (Spence et al., 2007) and 82% (Hanstock et al., 2016) 67 
of URS episodes during winter months occur with an infectious pathogen.  Non-infectious URS 68 
in athletes may be related to allergic rhinitis, asthma and/or exercise-induced 69 
bronchoconstriction.  70 
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Since reducing URS, particularly of infectious origin, may have implications for athletic 71 
performance, it is not surprising that a large amount of research has focused on nutritional 72 
strategies to improve immune function at rest, and/or favourably modify the immune response 73 
to exercise. Although the impact of a chronically high training load on immune function is still 74 
debated, it is documented that a single bout of prolonged, intense exercise transiently modifies 75 
a large number of immune variables. Following intense exercise an individual’s capacity to 76 
defend against pathogens is altered, resulting in what is referred to as an “open window” for 77 
infectious causes of URS, lasting up to 72 hours post-exercise depending on the intensity and 78 
duration of the exercise, and the immune marker measured (Moreira et al., 2009).  79 
Quantifying immunocompetence in athletes in the field and identifying changes that predict 80 
infection risk as a result of interventions is challenging. The gold standard (or most relevant 81 
outcome) may be clinical symptoms such as whether or not an individual actually contracts an 82 
infection, as confirmed by pathological tests, assuming that pathogen exposure is similar across 83 
intervention groups. However, in order to elucidate the underlying mechanisms that mediate 84 
any potential changes in infection risk following a nutrition intervention, it would also be 85 
pertinent to include immunological markers in laboratory research trials.  86 
This short review will provide an updated summary on  selected immune nutrition topics 87 
including dietary carbohydrate and protein intake, hydration status, antioxidants, vitamin D, 88 
bovine colostrum, and probiotics, including when evidence is available practical 89 
recommendations for the sport and exercise nutrition practitioner and/or athlete and coach 90 
(Table 1). For a more in-depth review, readers are referred to the latest consensus statement of 91 





It is well documented that carbohydrate intake is a fundamental part of an athlete’s diet, both 95 
in its ability to enhance physical performance and its role in recovery following exercise. 96 
Athletes adopting a train-low compete-high CHO intake approach may increase their risk of 97 
immune impairment during periods of restricted CHO intake (Burke, 2010). Previous work has 98 
shown that participants on low carbohydrate diets (less than 10% of energy from CHO) for 48 99 
– 72 hrs have larger circulating stress hormone (cortisol, adrenaline) and cytokine (IL1ra, IL6, 100 
IL10) responses when compared to normal or high CHO diets (Bishop, Walsh, Haines, 101 
Richards & Gleeson, 2001b). Whilst it should be noted that it is unusual for elite athletes to 102 
regularly have intakes as low as that outlined in the Bishop paper (<10% of daily energy intake 103 
from CHO equated to ~1.1 g/kg body mass per day); it is not unheard of for this to be the case 104 
for short periods. Athletes may adopt a low CHO intake lasting 1-3 days in specific scenarios 105 
e.g. making weight or during periods of tapering where training volume may decrease for 106 
competition preparations (Reale, Slater & Burke, 2017). In contrast, high CHO diets have been 107 
associated with blunted plasma cortisol responses to exercise due to preservation of plasma 108 
glucose, better maintenance of post-exercise plasma glutamine concentrations and attenuated 109 
exercise-induced disturbances in the number of circulating leukocytes, neutrophils and 110 
lymphocytes (Bishop, Walsh, Haines, Richards & Gleeson, 2001a; Gleeson, Blannin, Walsh, 111 
Bishop & Clark, 1998).  112 
The majority of evidence from the literature suggests that increasing CHO availability will act 113 
indirectly to reduce the stress hormone response to exercise and therefore limit exercise-114 
induced immune impairment. There is also some evidence to suggest the beneficial effects of 115 
consuming CHO during exercise can occur without any effect of plasma cortisol levels, 116 
although this is likely to be dependent upon intensity and duration (Green, Croaker & 117 
Rowbottom, 2003). Sixty grams per hour of CHO attenuates the rise in plasma cytokines during 118 
exercise, and reduces the trafficking of leukocyte subsets during prolonged (2.5h) endurance 119 
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running (Henson et al., 1998). In contrast, however, CHO feeding during marathon running 120 
appears ineffective in altering salivary secretory immunoglobulin-A secretion and reducing 121 
self-reported symptoms of URS (Nieman et al., 2002). Recent evidence also found that acute 122 
CHO ingestion before, during and after prolonged exercise had no benefit on in vivo immune 123 
responses with a novel antigen (Davison, Kehaya, Diment & Walsh, 2016).  124 
Whilst a substantial body of evidence supports the influence of carbohydrate availability (in 125 
terms of dietary intake or acute supplementation) on stress hormone responses and in vitro 126 
markers of immune function (Bishop, Walsh, Haines, Richards & Gleeson, 2001a; Gleeson et 127 
al., 1998), evidence is lacking with use of clinically relevant outcomes (integrated in vivo 128 
measures, incidence of URS). Despite the lack of studies showing a benefit of CHO on URS it 129 
is important to acknowledge that CHO intake and supplementation have consistently been 130 
shown to enhance aspects of performance and recovery. Subsequently if athletes achieve 131 
recommended intakes for CHO (Table 1) during training and competition, it may help control 132 
for any proposed impact of CHO availability on immune function. Periodised CHO intake to 133 
match training intensity and competition with periods of restriction to enhance training 134 
adaptations (Bartlett, Hawley & Morton, 2015; Burke, 2010) could offer a suitable compromise 135 
between fuelling and enhancing training adaptations and limiting the negative effects of low 136 
CHO availability upon the stress hormone response.  137 
 138 
Protein 139 
Immune function is reliant on rapid cell replication and generation of proteins such as cytokines 140 
and immunoglobulins. It is therefore not surprising that inadequate protein intake has been 141 
associated with compromised host defence and susceptibility to opportunistic infection. 142 
Although athletes typically appear to consume adequate amounts of protein, some individuals 143 
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may experience sub-optimal protein intake, for example during periods of heavy training and/or 144 
weight loss. Even in endurance athletes meeting the recommended daily protein intake of 1.6 145 
g/kg body mass (Tarnopolsky, 2004), there may be immunological benefits of further 146 
increasing dietary protein during intense training periods. Witard et al. (2014) found that during 147 
intensified training increasing daily dietary protein intake from 1.5 to 3 g/kg body mass (whilst 148 
maintaining a carbohydrate rich diet of 6 g/kg body mass per day) blunted the exercise-induced 149 
impairment in CD8+ T lymphocyte, total leukocyte and granulocyte redistribution observed in 150 
participants following a lower protein diet (Witard et al., 2014). Importantly the high protein 151 
diet resulted in significantly fewer self-reported URS, with the authors proposing that 152 
consumption of a high protein diet may help maintain immune surveillance during high-153 
intensity training. The exact dose for optimal immunological benefits during periods of 154 
intensified training may be somewhere between 1.5 and 3g/kg body mass, depending on the 155 
type of exercise conducted, but further research is warranted to establish clearer 156 
recommendations.  157 
There has also been interest in single amino acid supplementation to influence immune 158 
competence in athletes. Specifically the non-essential amino acid glutamine is an important 159 
fuel for immune cells in particular lymphocytes and macrophages (Castell & Newsholme, 160 
1997). Endurance exercise can reduce plasma glutamine (Castell & Newsholme, 1998) and it 161 
has been hypothesized that oral glutamine supplementation may enhance post-exercise 162 
immunity (Castell & Newsholme, 1997). However, the majority of studies have found that 163 
reduced plasma glutamine does not meaningfully contribute to exercise-induced immune 164 
impairment (Gleeson, 2008). Despite an attractive hypothesis, there is little evidence that 165 
glutamine supplementation influences immune responses to exercise.  166 
There remains a lack of randomised controlled trials assessing increased protein intake upon 167 
self-reported URS, and despite some mechanistic evidence for glutamine supplementation 168 
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showing immune benefits, to date there is limited evidence that glutamine supplementation is 169 
effective in abolishing the post-exercise immune cell impairment and URS. 170 
 171 
Hydration 172 
It is not unusual for athletes to commence training in a pre-existing fluid deficit. A combination 173 
of factors can lead to this predisposition, including failure to rehydrate between sessions or 174 
specific weight making strategies. The potential negative effects of hypohydration during 175 
exercise in laboratory settings are well documented; increased cardiovascular strain, elevated 176 
core temperature and increased perception of effort (Sawka & Coyle, 1999). Furthermore, a 177 
pre-exercise fluid deficit of as little as a 1.5-2.0% body mass loss (BML) has been suggested 178 
to negatively affect laboratory based exercise trials (Maughan & Shirreffs, 2004). In contrast, 179 
recent evidence suggests that in appropriate and representative environmental conditions of 180 
outdoor exercise where effective evaporative cooling can be maintained body mass losses of 181 
up to 3% can be well tolerated and have little negative impact upon exercise performance (Wall 182 
et al., 2015).  183 
With regard to the immune response to  moderate hypohydration there appears to be no 184 
negative effect on total or differential leukocyte numbers, lymphocyte function (Mitchell, 185 
Dugas, McFarlin & Nelson, 2002), neutrophil function, or antigen-stimulated cytokine 186 
production (Svendsen, Killer & Gleeson, 2014). As such, undertaking exercise in a 187 
hypohydrated state, at least within the range generally applicable to athletes, does not appear 188 
to have meaningful implications for cellular immunity.  189 
In contrast, significant reductions in salivary flow rates have been observed in exercising 190 
participants at a BML of 1.3-3% (Killer, Svendsen & Gleeson, 2015). Saliva contains numerous 191 
antimicrobial proteins (AMPs) that play an important role in mucosal immunity, and reductions 192 
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in salivary flow rate may therefore have implications for host defence.  To date, secretory IgA 193 
(SIgA) has been the most studied marker of mucosal immunity within athletic populations. The 194 
importance of salivary lysozyme (SLys) and salivary lactoferrin (SLac) have also gained 195 
recognition as both are present in mucosal secretions of the upper respiratory tract and 196 
understood to play an integral role in the innate immune system.  197 
Fortes and colleagues investigated SIgA and SLys following exercise-induced dehydration and 198 
subsequent overnight fluid restriction (3% BML) (Fortes, Diment, Di Felice & Walsh, 2012). 199 
Dehydration resulted in a significant decrease in SIgA concentration, with no change in 200 
secretion rate and conversely, no change in SLys concentrations but a significant reduction in 201 
secretion rate. Research has also identified transient changes in salivary AMPs during and 202 
immediately post-90 min exercise following 24 h fluid restriction, which had mostly returned 203 
to baseline values by 3 h post-exercise (Killer et al., 2015). Exercise in a state of mild 204 
hypohydration caused a reduction in saliva flow rate, yet induced greater secretion rates of 205 
SLac and higher concentrations of SIgA and SLys. 206 
These data suggest that prolonged exercise in a state of mild hypohydration (1-3%) may not 207 
detrimentally affect mucosal immunity. Whilst there remains a lack of evidence into incidence 208 
of URS and hydration status, it is unlikely that the reported small transient fluctuations in 209 
salivary AMPs would translate into clinical relevance. Furthermore, inconsistencies in the 210 
measurement of AMP concentrations vs secretion rates, variation in dehydration protocols 211 
(fluid restriction vs exercise-induced) and a wide range of levels of dehydration (percentage 212 
BML) are likely to contribute to the lack of clarity around the impact of hydration on mucosal 213 
immunity, in particular when deciphering any clinical significance. Future research should look 214 
to address some of these issues and establish if exercise-induced hypohydration in a range of 215 
environments (laboratory and field) can have a detrimental impact upon exercise-induced 216 





Strenuous exercise is associated with an acute increase in the production of free radicals 220 
(reactive oxygen species (ROS), and reactive nitrogen species (Powers, Nelson & Hudson, 221 
2011). An endogenous network of enzymatic (e.g. superoxide dismutase, glutathione 222 
peroxidase, catalase) and non-enzymatic antioxidants (e.g. vitamins A, C and E) exist to 223 
provide intracellular and extracellular protection against oxidant damage (Powers, Deruisseau, 224 
Quindry & Hamilton, 2004). Whilst it is acknowledged these antioxidant defences adapt with 225 
training, it has long been debated whether they are sufficient to counter oxidant production 226 
during strenuous exercise. Early investigations highlighting the damaging effects of oxidants 227 
on muscle and cells led to a proposed role of antioxidant status in exercise-induced immune 228 
dysfunction following prolonged exercise (Powers et al., 2011).  229 
Of all the potential exogenous antioxidant supplements, the essential nutrient vitamin C has 230 
received the greatest attention as a strategy to support immune health in athletes (Nieman et 231 
al., 2002). Initially, interest was also partly due to preliminary evidence of the prophylactic 232 
benefit of vitamin C on the common cold. The current evidence, however, provided by the 233 
latest Cochrane review, reports that routine vitamin C supplementation (> 0.2 g per day) does 234 
not reduce the risk of developing a cold in the general population but such regular 235 
supplementation (as opposed to upon onset of symptoms) appears to reduce the duration and 236 
severity of colds (Hemilä & Chalker, 2013). In contrast, pre-specified sub-group analysis of 237 
trials in this review concluded that there is firm evidence that vitamin C supplementation 238 
between 0.25 and 1.0 g/day results in reduced number of participants reporting URS under 239 
periods of physical stress with or without cold stress (marathon runners, skiers and soldiers on 240 
subarctic operations). The underlying mechanism(s) of such effects remains unclear, 241 
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particularly as any role of exercise-induced oxidant production in alterations of immune 242 
dysfunction has not been shown consistently (Nieman et al., 2002). Additional evidence has 243 
purported benefits of vitamin C in non-infectious causes of URS (e.g. exercise-induced 244 
bronchoconstriction) following exercise (Hemilä, 2013).   245 
Investigation of other essential nutrients with antioxidant potential (e.g. vitamin E) or multiple 246 
vitamins have largely been unsuccessful with concerns over pro-oxidant/pro-inflammatory 247 
effects in large doses or interference with the role of ROS in key signalling processes of training 248 
adaptation (Nieman & Mitmesser, 2017). Focus in this area has shifted towards other 249 
nutritional compounds in the human diet such as polyphenols, albeit the emerging evidence of 250 
the effects of these interventions on URS risk in athletes also appear to be independent of any 251 
antioxidant properties (e.g. direct anti-pathogenic pathways) (Somerville, Braakhuis & 252 
Hopkins, 2016). There is lack of conclusive evidence that exercise-induced oxidant production 253 
is detrimental to athlete health, including host defence. Nevertheless, the additional evidence 254 
of the effect of vitamin C on duration and severity of URS means evaluation on an individual 255 
athlete basis may be clinically worthwhile. The evidence of higher regular intake of vitamin C 256 
and reduced incidence of URS, however, should not be ignored. It is important to stress that 257 
these benefits were evident within a range of doses (0.25 – 1.0 g per day) that were not 258 
particularly high, and thus excess consumption may be easily achieved through use of over-the 259 
counter vitamin C supplements. It appears that these benefits are only apparent in those exposed 260 
to short-term unaccustomed physical stress. Such findings may have limited application to the 261 
trained athlete who has regular (long-term) exposure to such stress (i.e. training and 262 
competition). 263 
 264 
Vitamin D 265 
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Over the past decade, there has been emerging evidence highlighting the role that vitamin D 266 
may have in athlete health (Owens, Fraser & Close, 2015). Commonly known for its role in 267 
bone health (Ebeling, 2014) and muscle function (Owens et al., 2015) it is also increasingly 268 
recognised for its role in inflammation and aspects of innate and acquired immunity (He et al., 269 
2016).  270 
Unlike other vitamins that are primarily obtained through diet, physiological sufficiency for 271 
vitamin D can be met through endogenous synthesis via UV irradiation of the skin’s dermis. 272 
The cutaneous production of vitamin D is highly variable and dependent upon both 273 
environmental and individual factors. These include season, time of day, amount of cloud 274 
cover, skin pigmentation, age, clothing, and  use of high-factor sunscreen (Chen et al., 2007). 275 
Furthermore, vitamin D synthesis drops in winter months at latitudes greater than 35-37° due 276 
to insufficient UVB photons reaching the Earth’s surface (Webb, Kline & Holick, 1988).  277 
Adequate concentration has been previously defined as serum 25 hydroxy vitamin D 278 
(25(OH)D) >50 nmol/L by the US Institute of Medicine. However, within the literature, there 279 
is a lack of consensus as to what constitutes vitamin D deficiency and what might be classified 280 
as an insufficiency for elite athlete health and performance. It is beyond the scope of this review 281 
to discuss what constitutes sufficient or optimal circulating concentrations of 25(OH)D, so 282 
readers are referred to He et al (2016) for more information (He, Aw Yong, Walsh & Gleeson, 283 
2016). The prevalence of deficiency and sufficiency in athletes varies by, training location, 284 
sport (Larson-Meyer & Willis, 2010) and skin colour (Pollock, Dijkstra, Chakraverty & 285 
Hamilton, 2012), with deficiency being greater in the winter months (Farrokhyar et al., 2015). 286 
There is growing evidence that vitamin D likely plays a key role in both innate and acquired 287 
immunity through its modulation of gene expression (Kamen & Tangpricha, 2010).  Vitamin 288 
D upregulates gene expression of antimicrobial peptides, which are important regulators in 289 
innate immunity, and downregulate expression of inflammatory cytokines (He et al., 2016). 290 
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Furthermore, vitamin D is also found to have an immunomodulatory effect on T and B-291 
lymphocytes in acquired immunity (Von Essen et al., 2010).  292 
A small number of studies have reported negative associations between vitamin D 293 
concentration and self-reported URS in athletes (He et al., 2013) and military personnel (Laaksi 294 
et al., 2007). In a study of endurance athletes, those in a Vitamin D deficient status group 295 
25(OH)D < 30nmol/L), reported greater number of URS days and higher symptom-severity 296 
scores compared to counterparts with greater circulating vitamin D concentrations (He et al., 297 
2013). Elite athletes reporting with URS who had a positive virology/bacteriology result 298 
(infectious group) or athletes with a mild to moderate leucocytosis (suggestive group) had 299 
significantly lower levels of circulating 25(OH)D levels than athletes with a negative 300 
virology/bacteriology count and normal differential leukocyte count (Cox et al., 2008). In a 301 
military setting young Finnish conscripts who had low circulating 25(OH)D concentrations 302 
(defined by the authors as <40 nmol/L) had significantly more duty days lost to respiratory 303 
infection during 6 months of training and were 1.6 times more likely to miss duty due to 304 
respiratory infection than those with a circulating 25(OH)D >40 nmol/L (Laaksi et al., 2007).  305 
Although causality cannot be established from these cross-sectional comparison studies of 306 
physically active individuals, they are in agreement with RCTs of general populations that 307 
show reduced respiratory infections with daily or weekly vitamin D supplementation, 308 
particularly in those with deficiency (< 25-30 nmol/L circulating 25(OH)D) (Berry, Hesketh, 309 
Power & Hyppönen, 2011).  310 
 311 
Bovine colostrum 312 
Bovine colostrum (COL) is the initial milk produced by a cow in the first few days following 313 
parturition. In addition to a different composition of macronutrients (higher percentage of 314 
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protein, lower percentage of lactose and fat) compared to mature milk (Ontsouka, Bruckmaier 315 
& Blum, 2003), COL is richer in antimicrobial, growth and immune factors (Uruakpa, Ismond 316 
& Akobundu, 2002). In fact, the bioactivity of COL is at its greatest in the first milking with 317 
the concentrations of such components decreasing over the subsequent days (Korhonen, 318 
Marnila & Gill, 2000). Although sharing a homologous composition to human colostrum, the 319 
concentrations of immune factors in COL are in vastly greater concentrations (Shing, Peake, 320 
Suzuki, Jenkins & Coombes, 2013). Such bioactivity has led to suggestions that COL could 321 
enhance human immune function and hence aid prophylaxis of infections. 322 
A recent meta-analysis (Jones, March, Curtis & Bridle, 2016) of five randomised controlled 323 
trials concluded COL supplementation reduces the incidence rate of episodes and total number 324 
of days of URS during exercise training (cyclists, distance runners, recreational athletes, 325 
swimmers). The magnitude of these reductions (URS days: 44%; URS episodes 38%) are 326 
greater than the smallest clinically important difference, but the low precision of the individual 327 
study estimates (as a result of small sample sizes and hence low number of events) means that 328 
further trials will likely change the best estimate of the average effect of COL. The minimum 329 
and/or the optimum dose of COL for benefit on incidence of URS is yet to be confirmed, but 330 
there is preliminary tentative (observational) evidence suggesting 20 g per day may result in 331 
superior protection than 10 g (Jones et al., 2016) (Table 1). There remains a lack of evidence 332 
to determine whether COL supplementation can reduce duration or severity of URS episodes 333 
in athletes.  334 
Given the somewhat uncertainty surrounding the causes of self-reported URS with exercise, 335 
there may be a number of potential mechanisms responsible for the effects of COL on URS 336 
during exercise training. In-depth reviews of the underlying mechanisms in the effects of COL 337 
have been discussed extensively elsewhere (Bermon et al., 2017; Davison, 2012). Briefly, one 338 
proposed mechanism is that the small bioactive constituents of COL, or their metabolites, 339 
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appear in the circulation after consumption and have immune-enhancing effects on host 340 
immunity (Jones et al., 2016). Recently, COL supplementation induced greater sensitivity of 341 
in vivo immune responses to a novel antigen (experimental CHS) following prolonged exercise 342 
(Jones et al., 2018). Whilst recognising that the specific mechanisms of action of COL may 343 
differ between populations, reports of reduced incidence of respiratory infections in other at 344 
risk groups (with immune deficiency/recurrent infections) are further examples of available 345 
evidence supporting an hypothesis that use of COL can lead to changes in host defence against 346 
pathogenic causes of URS (Cesarone et al., 2007; Patıroğlu & Kondolot, 2013).  347 
 348 
Probiotics and Prebiotics 349 
The human intestine represents the largest mass of lymphoid tissue in the body and is resident 350 
to thousands of bacterial taxa (Wylie et al., 2012). The adult gastrointestinal immune system 351 
comprises of a stable alliance among the commensal microbiota, immune mediators, and the 352 
epithelial barrier. All three components are essential for function and maintenance of a stable 353 
and mature intestinal immune system. Nutritional supplementation to support the gut 354 
microbiota is a proposed means to maintain immune competence and reduce URS risk (Hao, 355 
Dong & Wu, 2015).    356 
It is now recognised that the species composition of the microbiota can be modified by 357 
alterations in dietary intake. Regular consumption of probiotic bacteria can positively modify 358 
the composition of the gut microbiota and influence immune health (Round & Mazmanian, 359 
2009). Alternatively, a prebiotic, a selectively fermented ingredient that allows specific 360 
changes, both in the composition and/or activity in the gastrointestinal microbiota can confer 361 
benefits upon host well-being and health (Gibson et al., 2017). However, to date there are 362 
currently no published studies on the efficacy of prebiotics to reduce URS in athletes. Non-363 
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infectious causes of URS such as exercise-induced bronchoconstriction has shown a favourable 364 
response to prebiotics (Williams et al., 2016).  365 
A large number of studies have been conducted investigating the effects of probiotics on URS 366 
in the non-athlete general population, and readers are referred to the latest Cochrane systematic 367 
review for more detail (Hao et al., 2015). The review concluded that probiotics were better than 368 
placebo with fewer participants experiencing at least one episode of acute URS, but there was 369 
no difference when measuring rate of episodes of URS or the duration of episodes (Hao et al., 370 
2015).   371 
With regard to probiotic use and athletes, there are few well-conducted large scale randomised 372 
controlled trials, but readers are referred to a 2015 review of the probiotic literature in athletes 373 
for more detail (Pyne et al., 2015). Briefly, they identified 15 relevant experimental studies 374 
from 2006 to 2014 that investigated the clinical and immunological effects of probiotic 375 
supplementation in trained individuals; five randomised placebo controlled studies reported 376 
reductions in self-reported URS frequency, with three reporting trivial to no effects (Pyne et 377 
al., 2015).  378 
A randomised crossover trial showed benefit from a daily dose of 1.3x1010 colony forming 379 
units (CFU) Lactobacillus fermentum for 28 days in distance runners during a winter training 380 
period (Cox, Pyne, Saunders & Fricker, 2010). The number of days, and severity of self-381 
reported URS was less (~50%) in those receiving the probiotic compared to placebo. This was 382 
coupled with a two-fold greater change in whole blood culture interferon-γ with the probiotic; 383 
however, there were no changes in salivary IgA, or IL-4 and IL-12 (Cox et al., 2010). Further 384 
evidence in support of probiotic feeding showed that 16 weeks of Lactobacillus casei Shirota 385 
(1.3x1011 cells per day)  reduced the proportion of active individuals reporting URS by 36%, 386 
reduced the number of URS episodes (1.2 vs 2.1), and increased salivary IgA over the course 387 
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of the study (Gleeson, Bishop, Oliveira & Tauler, 2011). However, there was no difference in 388 
duration of symptoms (Gleeson et al., 2011). In contrast, a follow up study using a probiotic 389 
bacteria strain of Lactobacillus salivarius, 2x1010 CFU for 16 weeks failed to reduce the 390 
frequency of URS in an athletic cohort or modify markers of immune function (Gleeson et al., 391 
2012), highlighting issues with strain specificity. Further issues arise with potential sex 392 
differences in responsiveness to probiotic treatment as 11 weeks of Lactobacillus fermentum 393 
(1.0x109 cells per day) was able to reduce illness load (severity x duration) of URS by 31% in 394 
males but not females (West et al., 2011).  395 
It appears there is a growing body of evidence that probiotic supplementation may be beneficial 396 
in reducing the frequency of URS during periods of high training load. A greater number of 397 
well-controlled studies with probiotics are required to clarify dose response, strain choice and 398 
elucidate mechanisms of action within athlete populations. Furthermore, prebiotics, which act 399 
by increasing the growth and activity of non-pathogenic commensal bacteria at a genus level 400 
maybe a viable alternative or have an additive effect as a synbiotic (combined probiotic and 401 
prebiotic intervention) and research into their use is warranted.   402 
 403 
Conclusions 404 
The risk of URS in athletes typically cluster around important periods of travel, competition 405 
and intense periods of training. In order to limit the detrimental effects of URS on training 406 
completion or competitive performance, elite athletes seek strategies to prevent or manage such 407 
events. There is a need to understand whether the nutritional practices adopted by elite athletes’ 408 
increase their risk of URS. The nutritional interventions discussed in this review show some 409 
promising mechanistic evidence for an immunomodulatory effect within athletes, yet well-410 
powered randomised controlled trials reporting reduced incidence in URS are not widely 411 
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available. There is need for more randomised controlled trials to establish the efficacy of 412 
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Table 1 summary of the effects of nutritional interventions on upper respiratory symptoms in athletes and practical recommendations 629 
 
Nutrient 






Practical recommendations In vitro Ex vivo In vivo 
CARBOHYDRATE  [✓] [✓] [] 

Lack of RCTs 
investigating 
effect on URS 
Further RCTs to establish if 
training in a low CHO state or 
CHO feeding during and after 
prolonged exercise impacts on 
URS and integrated in vivo 
measures of immune function 
Athletes consuming 30–60 g CHO per hour during 
sustained intensive exercise will aid the demands of 
physical and metabolic recovery. Immediately post 
exercise (0-2 hours) athletes are recommended to 
consume 1.0-1.2 g/kg body mass, however the 
absolute amount should be adjusted depending on the 
nature of the training session they have completed 
and the duration of the recovery period before the 
next training session.  
These intakes may attenuate the rise in stress 
hormones and indirectly limit the degree of exercise-
induced immune impairment.  
Athletes undergoing train-low strategies should 
carefully periodise these sessions within their season 
to limit any potential impact this may have on 











total protein or 
glutamine 
supplementation. 
Further RCTs to establish if 
additional total protein or 
glutamine supplementation 
impacts on URS and integrated 
in vivo measures of immune 
function  
Athletes are recommended to consume adequate 
daily amounts of protein (1.2  - 1.7 g/kg body mass), 
depending on the nature of their training, to help 
maintain sufficient whole body protein metabolism. 
Subsequently this may support correct immune 
function.  
It should also be noted that the pattern of ingested 
protein can affect whole-body protein metabolism, 
~20-30 g at regular (~3 h) intervals throughout the 
26 
 
day is recommended for maximising net protein 
balance.  
Further supplementation of protein intake or 
single/multiple amino acids is not recommended to 
improve immunity and reduce URS incidence. 
 HYDRATION  [✓] [?] [] 
Lack of RCTs 
investigating 
effect on URS 
Lack of evidence for an 
association between 
hypohydration and self-
reported URS, future research 
should look to establish if 
higher levels of hypohydration 
can impair immune function 
and if this is environment 
dependent.  
Athletes should be advised to maintain fluid balance 
throughout day-to-day training to ensure optimal 
performance and health, especially when away at 
training camps either in the heat or at altitude where 
fluid losses may be elevated, and infection risk 
increased. 
 
Daily monitoring of body mass during training 
camps is a simple and inexpensive method 
commonly used to monitor changes in fluid balance. 
In addition, regular monitoring of either urine 
osmolality or specific gravity can indicate normal 
ranges for individual athletes and therefore highlight 
fluid imbalances quickly and effectively.   
ANTIOXIDANT 
SUPPLEMENTATION 
[✓] [✓] [] 

Meta-analysis of 
RCTs of heavy 
acute exercise 
(and/cold) stress  
 
Given the lack of evidence of 
vitamin C supplementation to 
reduce reporting URS in 
general population, further 
RCTs are needed during 
periods of short-term and long-
term physical stress with 
changes in URS supported by 
clinically relevant 
immunological markers.  
Athletes are recommended to consume a nutrient-
dense diet with a variety of fresh fruits and 
vegetables. In the absence of any rare nutritional 
(e.g. vitamin C) deficiencies, most athletes are 
recommended to avoid excessive supplementation 
with antioxidant vitamins. 
Supplementation of 0.25 – 1.0 g/day of vitamin C to 
reduce URS may be useful in some athletes when 





[✓] [✓] [] 
 
RCTs of vitamin D 
supplementation (to correct 
deficiency) to establish 
Practical recommendations seem to be effective in 
those who are deficient (< 30 nmol/L) and these can 




RCTs in general 
population 
whether effect on URS in other 
populations can be shown in 
athletes. Assessment of URS 
should be supported by 
integrated in vivo measures of 
immune function 
although considerations must be made for latitude 
and skin type.  
 
Seasonal screening for vitamin D deficiency is 
recommended throughout the year in athletes.  
Bespoke strategies can then be put in to place which 
either involve maintenance (1000 - 2000 IU/day) or 
increasing intake to reverse a deficiency.  
Studies show that consuming a 1,000 to 2,000 
IU/day vitamin D3 supplement during winter can 
achieve sufficiency in most individuals. However, up 
to 4,000 IU/day may be needed if starting from 
deficiency. Furthermore, those training indoors or 
individuals required to wear protective or religious 
clothing in the summer may also benefit from the 
1,000 IU/day vitamin D3 recommendation. 
 
In the absence of deficiencies, most athletes are 





[✓] [✓] [✓] 
 
Meta-analyses of 
RCTs in athlete 
populations 
Low precision of estimates of 
effect on URS need to be 
followed up with appropriately 
designed and adequately 
powered RCTs. 
 Key mechanisms of action 
need to be elucidated. 
Consider daily supplementation (10-20 g) of bovine 
colostrum particularly during periods of greatest 
URS risk (e.g. winter period, training camps, long 
haul travel and competition). 
PROBIOTICS [✓] [✓] [?] 
 
Numerous RCTs 
in athletes and 
meta-analyses of 
Well-controlled research 
studies are required to establish 
dose and strain specific 
responses of probiotic 
interventions.  Furthermore, 
To ensure colonisation of bacterial species in the gut, 
implementation of probiotic supplementation is 
recommended to commence at least 14 days prior to 
overseas travel or competition. With a strain specific 
consensus lacking, a multi-strain probiotic 
28 
 
RCTs in general 
population 
mechanisms in elite athletes 
need to be elucidated. A viable 
alternative treatment may be a 
synbiotic (combined probiotic 
and prebiotic intervention) and 
research into their use is 
warranted.  
combining species from the genus’s lactobacillus and 
bifidobacterium with the viable number of cells per 
species greater than 1x109 CFU per day should be 
considered to ensure the greatest survival to the gut, 






Figure 1 The proposed J-shaped (A) (Nieman, 1994) and S-shaped (B) (Malm, 2006) 633 
relationship between exercise and risk of (respiratory) infection 634 
